tiprankstipranks
Advertisement
Advertisement

Trulieve Cannabis Expands Senior Secured Notes Financing

Story Highlights
  • On January 29, 2026 Trulieve completed a second US$60 million tranche of 10.5% senior secured notes, bringing total issuance to US$200 million for debt financing due 2030.
  • The new notes, secured by Trulieve US shares and carrying restrictive covenants and redemption features, strengthen Trulieve’s capital resources for capex and general corporate purposes while targeting a future CSE listing for added liquidity.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Trulieve Cannabis Expands Senior Secured Notes Financing

Claim 30% Off TipRanks

Trulieve Cannabis ( (TSE:TRUL) ) has shared an announcement.

On January 29, 2026, Trulieve Cannabis Corp. closed a second tranche of its private placement of 10.5% senior secured notes due 2030, issuing an additional US$60 million and bringing the total outstanding principal under the notes to US$200 million after the first tranche closed on December 17, 2025. The additional notes, issued at US$1,000 plus accrued interest from December 17, 2025 to January 29, 2026, carry the same 10.5% coupon and terms as the original issuance, are senior secured by a pledge of shares in subsidiary Trulieve US, and include covenants restricting dividends, new indebtedness, asset sales and certain affiliate transactions, with provisions for optional redemption and change-of-control protection for noteholders. Conducted on a best-efforts basis with Canaccord Genuity as sole agent and bookrunner, the unregistered private placement strengthens Trulieve’s capital structure and provides US$200 million in debt financing earmarked for capital expenditures and general corporate purposes, with the company planning to seek a listing of the notes on the Canadian Securities Exchange following the expiry of the statutory hold period, potentially enhancing liquidity and access for fixed-income investors.

The most recent analyst rating on (TSE:TRUL) stock is a Buy with a C$20.00 price target. To see the full list of analyst forecasts on Trulieve Cannabis stock, see the TSE:TRUL Stock Forecast page.

Spark’s Take on TSE:TRUL Stock

According to Spark, TipRanks’ AI Analyst, TSE:TRUL is a Neutral.

Trulieve Cannabis demonstrates strong revenue growth and positive technical momentum, but faces challenges with profitability and valuation. The earnings call provided a balanced view of growth initiatives and existing pressures.

To see Spark’s full report on TSE:TRUL stock, click here.

More about Trulieve Cannabis

Trulieve Cannabis Corp. is an industry-leading, vertically integrated U.S. cannabis company and multi-state operator with strong market positions in Arizona, Florida and Pennsylvania. The company focuses on building scale in retail and distribution through a hub strategy and offers a portfolio of innovative, high-quality cannabis products aimed at enhancing patient and customer access. Trulieve’s shares trade on the Canadian Securities Exchange under the symbol TRUL and on the OTCQX market under the symbol TCNNF.

Average Trading Volume: 271,050

Technical Sentiment Signal: Buy

Current Market Cap: C$2.03B

Find detailed analytics on TRUL stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1